ESLA · ISSUER CIK 1844417
Estrella Immunopharma, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Estrella Immunopharma, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 202619:23 | Aug 25, 2026 | ESLA | CEO, Director | M · Exercise | $0.82 | +100,000 | 397,437 | +34% | $82K | ||
| Aug 25, 202621:55 | Aug 18, 2026 | ESLA | Chief Financial Officer | M · ExerciseLate 7d | $0.82 | +100,000 | 365,488 | +38% | $82K |